| El-Hibri FuadDirector · 402 transactions | — | 4.64M†as of Dec 2021 | 1.17M | — | 2.92M |
| Intervac, L.L.C.10% owner · 162 transactions | — | 4.34Mas of Sep 2012 | — | — | 307.0K |
| Biopharm, L.L.C.10% owner · 3 transactions | — | 2.27Mas of May 2010 | — | — | — |
| Gibellini MauroSVP, Corporate Dev. · 32 transactions | — | 1.40M†as of Jun 2007 | 41.5K | — | 41.5K |
| Biologika, L.L.C.Member 13(d) group owning >10% · 54 transactions | — | 1.40Mas of Jun 2008 | — | — | 30.0K |
| Michigan Biologic Products, Inc.Member 13(d) group owning >10% · 568 transactions | — | 1.27Mas of Mar 2008 | — | — | 665.4K |
| Mulligan SeamusDirector · 1 transaction | — | 1.20M†as of Mar 2019 | 7.6K | — | — |
| Kramer RobertPresident and CEO, Director · 162 transactions | — | 506.1Kas of Jun 2023 | 1.23M | — | 583.7K |
| Papa Joseph CPresident and CEO, Director · 4 transactions | — | 493.2K | 470.2K | 60.0K | — |
| Lindahl Richard SEVP, Chief Financial Officer · 52 transactions | — | 374.1K | 511.6K | 3.0K | — |
| Glessner ColeenEVP, Quality & Ethics, and CPL · 26 transactions | — | 202.2K | 328.4K | — | 30.6K |
| Fox Jennifer LynneEVP, Ext Aff, GC, Corp Sec · 18 transactions | — | 186.4Kas of Jul 2024 | 188.9K | — | — |
| Hartzel WilliamSVP, Bioservices · 17 transactions | — | 185.6K | 177.6K | — | — |
| Lowry Simon CSVP, R&D, CMO · 5 transactions | — | 177.9K | 192.1K | — | — |
| Havey AdamEVP, Business Operations · 127 transactions | — | 174.4Kas of Jun 2023 | 460.5K | 98 | 250.7K |
| Perl JessicaSVP, General Counsel, Corp Sec · 5 transactions | — | 165.3K | 166.8K | — | — |
| Williams Paul AnthonySVP, Products Business · 24 transactions | — | 162.1K | 179.9K | — | 4.0K |
| Fowler Neal FranklinDirector · 5 transactions | — | 160.8K | 195.8K | — | 35.0K |
| Harsanyi ZsoltChairman, Director · 112 transactions | — | 149.1K | 305.6K | — | 157.8K |
| Abdun-Nabi DanielCEO, Director · 175 transactions | — | 144.6K†as of Mar 2019 | 928.3K | 1.5K | 654.6K |
| Sullivan Louis WDirector · 49 transactions | — | 139.1Kas of Apr 2025 | 305.2K | — | 145.0K |
| DeGolyer Donald WDirector · 9 transactions | — | 130.7K | 195.8K | — | 66.1K |
| Richard RonaldDirector · 74 transactions | — | 123.8K | 370.4K | — | 237.1K |
| White Marvin LDirector · 25 transactions | — | 113.8K | 191.6K | — | 47.4K |
| Dayal Sujata TyagiDirector · 8 transactions | — | 101.5K | 122.9K | — | 22.3K |
| Katkin KeithDirector · 7 transactions | — | 96.3K | 119.6K | — | 23.3K |
| Saran AtulEVP, Chief Strat & Dev Officer · 32 transactions | — | 86.6Kas of Feb 2023 | 105.4K | — | — |
| Zoon Kathryn CDirector · 37 transactions | — | 81.0K | 160.4K | — | 80.5K |
| Strei KatherineEVP, Chief HR Officer · 36 transactions | — | 62.8Kas of Feb 2023 | 67.3K | — | — |
| Hauer Jerome MDirector · 45 transactions | — | 57.5Kas of May 2023 | 195.2K | — | 132.7K |
| Joulwan George ADirector · 24 transactions | — | 40.2Kas of May 2022 | 82.1K | — | 43.2K |
| Fowler John D JrDirector · 2 transactions | — | 30.4K | 30.4K | — | — |
| Niederhuber JohnDirector · 7 transactions | — | 30.3Kas of May 2016 | 30.3K | — | — |
| Chatfield StevenEVP, BioSciences · 108 transactions | — | 28.0Kas of Mar 2013 | 80.5K | — | 57.5K |
| Elsey R DonChief Financial Officer · 115 transactions | — | 26.6Kas of Mar 2012 | 138.4K | 300 | 90.5K |
| Labinger BarryEVP, Biosciences Div. · 14 transactions | — | 25.2Kas of Nov 2015 | 69.5K | — | 39.5K |
| Bailey SueDirector · 63 transactions | — | 24.4Kas of Mar 2021 | 148.1K | — | 125.0K |
| Lockhart StephenSVP Product Development · 28 transactions | — | 23.6Kas of Nov 2010 | 54.4K | — | 47.5K |
| Keese KyleEVP, BioSciences Division · 87 transactions | — | 18.8Kas of Mar 2011 | 62.5K | — | 56.1K |
| Kirk SeanEVP, Manufacturing & Tech Ops · 16 transactions | — | 17.8Kas of Mar 2021 | 24.2K | — | 16.1K |
| Esposito DeniseCLO · 41 transactions | — | 11.9Kas of Dec 2008 | 34.4K | — | 34.4K |
| Smith Karen L.EVP, Chief Medical Officer · 3 transactions | — | 11.9Kas of May 2021 | 5.9K | — | — |
| Arcuri EdwardCOO · 2 transactions | — | 3.8Kas of May 2007 | 76.7K | — | — |
| Zink ThomasSVP & CMO · 2 transactions | — | 990as of May 2007 | — | 1.0K | — |
| Microscience Investments LTDReporting owner · 1 transaction | — | 0as of Mar 2007 | — | — | — |